In contrast, after in vitro stimulation, T cells from VAC patients have a higher frequency of CD69 in T cells that have reduced the amount of TCR/CD3 complexes (reduction of CD3 MFI) similar to the response of HD T cells (Figure 2D) and in a higher proportion to patients who did not receive DCs (NV). This evidence concerns the gene CD69 and Huntington disease.